SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hypertension Diagnostics Inc (HDII)
HDII 0.00010000.0%Sep 24 3:50 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eman03 who started this subject7/25/2000 7:31:37 PM
From: scott_jiminez  Read Replies (1) of 120
 
HDI had an SEC filing yesterday updating their stock option plan. One reading of this could be that this was done in anticipation of hiring a significant number of new personnel. The company is also advertising for sales positions on their website.

While this is all purely speculative, the facts are consistent with an expectation of a much higher level of sales of the Profilor(s). If this is the case, it is quite encouraging that it's occurring prior to FDA approval of the CVProfilor DO-2020 System. In other words, it may be the case that the sales of the CR-2000 are so strong that they require this expansion of the company. If the DO-2020 system gets approval, this company and this stock could really take off.

Idle speculation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext